Literature DB >> 10958277

Myocardial sympathetic innervation in the athlete's sinus bradycardia: is there selective inferior myocardial wall denervation?

M Estorch1, R Serra-Grima, A Flotats, C Marí, L Bernà, A Catafau, J C Martín, A Tembl, J Narula, I Carrió.   

Abstract

BACKGROUND: Sinus bradycardia in trained athletes is predominantly a manifestation of increased vagal tone, but it is not known whether an alteration in the cardiac sympathetic system can contribute to blunted chronotropic response. This study assessed the integrity of the sympathetic system in trained athletes with sinus bradycardia by means of the iodine-123-metaiodobenzylguanidine (123I-MIBG) procedure. METHODS AND
RESULTS: Fourteen athletes with sinus bradycardia and 8 athletes with a normal heart rate were explored by means of planar and single photon emission computed tomography MIBG studies. The heart/mediastinum ratio, regional myocardial distribution, and percent of regional myocardial MIBG uptake were evaluated. The heart/mediastinum ratio in athletes with sinus bradycardia was 1.87+/-0.10, and in athletes with a normal heart rate, the heart/mediastinum ratio was 1.86+/-0.16 (P = not significant). In athletes with sinus bradycardia, the regional distribution of MIBG showed an inferior and apical uptake defect in 8 athletes, an inferior, apical, and septal defect in 3 athletes, an inferior defect in 1 athlete, and normal distribution in 2 athletes (14%). In athletes with a normal heart rate, the regional distribution of MIBG showed an apical uptake defect in 3 athletes and normal distribution in 5 athletes (63%). The percent of regional MIBG uptake in the inferior region was significantly reduced in athletes with sinus bradycardia (44%+/-13% vs. 72%+/-11%, P<.01).
CONCLUSION: These results show severely reduced myocardial MIBG distribution in the inferior region in athletes with sinus bradycardia, suggesting selective inferior myocardial wall sympathetic denervation, which may be related to increased vagal tone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958277     DOI: 10.1067/mnc.2000.105550

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  Common ECG changes in athletes.

Authors:  N Hanne-Paparo; Y Drory; Y Schoenfeld; Y Shapira; J J Kellermann
Journal:  Cardiology       Date:  1976       Impact factor: 1.869

2.  False-positive defects in technetium-99m sestamibi myocardial single-photon emission tomography in healthy athletes with left ventricular hypertrophy.

Authors:  P Bartram; J Toft; B Hanel; S Ali; F Gustafsson; J Mortensen; B Hesse
Journal:  Eur J Nucl Med       Date:  1998-09

3.  Scintigraphic assessment of regional cardiac adrenergic innervation.

Authors:  M W Dae; J W O'Connell; E H Botvinick; T Ahearn; E Yee; J P Huberty; H Mori; M C Chin; R S Hattner; J M Herre
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

4.  Physical training, bradycardia, and autonomic nervous system.

Authors:  B Ekblom; A Kilbom; J Soltysiak
Journal:  Scand J Clin Lab Invest       Date:  1973-11       Impact factor: 1.713

5.  Electrocardiographic and echocardiographic characteristics of female athletes.

Authors:  K P George; L A Wolfe; G W Burggraf; R Norman
Journal:  Med Sci Sports Exerc       Date:  1995-10       Impact factor: 5.411

6.  Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography.

Authors:  S K Rerych; P M Scholz; D C Sabiston; R H Jones
Journal:  Am J Cardiol       Date:  1980-02       Impact factor: 2.778

7.  Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

Authors:  Y Magnusson; S Marullo; S Hoyer; F Waagstein; B Andersson; A Vahlne; J G Guillet; A D Strosberg; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

8.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

Review 9.  The electrocardiogram and the athlete.

Authors:  J A Ferst; B R Chaitman
Journal:  Sports Med       Date:  1984 Sep-Oct       Impact factor: 11.136

10.  Contrasting reflex influences of cardiac afferent nerves during coronary occlusion.

Authors:  L C Weaver; L M Danos; R S Oehl; R L Meckler
Journal:  Am J Physiol       Date:  1981-04
View more
  5 in total

Review 1.  Ionic mechanisms and vectorial model of early repolarization pattern in the surface electrocardiogram of the athlete.

Authors:  Eduardo C Barbosa; Alfredo de S Bomfim; Paulo R Benchimol-Barbosa; Paulo Ginefra
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-07       Impact factor: 1.468

Review 2.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

3.  Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.

Authors:  Teresa Pellegrino; Mario Petretta; Serena De Luca; Stefania Paolillo; Antonio Boemio; Raffaella Carotenuto; Maria Piera Petretta; Carmine di Nuzzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

4.  Differential effects of variation in athletes training on myocardial morphophysiological adaptation in men: focus on ¹²³I-MIBG assessed myocardial sympathetic activity.

Authors:  Douglas Pinheiro Miranda; Marcelo José dos Santos; Vera Maria Cury Salemi; Edmundo Pereira Caparelli de Oliveira; Hein J Verberne; Euclides Timóteo da Rocha
Journal:  J Nucl Cardiol       Date:  2014-03-14       Impact factor: 5.952

Review 5.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.